Legal Opinion

Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc.

District Court, D. Delaware

Decided July 22, 2025No. 1:23-cv-00101Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE NOVO NORDISK, INC. and NOVO NORDISK A/S, Plaintiffs, Civil Action No. 23-101-CFC v. ANDA CASE MYLAN PHARMACEUTICALS INC., Defendant. Travis J. Murray and Brian P. Egan, MORRIS, NICHOLS, ARSHT & TUNNELL LLP, Wilmington, Delaware; Nicholas P. Groombridge, Josephine Young, Peter H. Sandel, Jenny C. Wu, Daniel J. Klein, Naz E. Wehrli, Joshua D. Reich, and Scott Miller, GROOMBRIDGE, WU, BAUGHMAN & STONE LLP, New York, New York; Philip S. May, GROOMBRIDGE, WU, BAUGHMAN & STONE LLP, Washington, D.C. Counsel for Plaintiffs Stamatios…

2Cases cited12 opinions

  1. Rosenau v. Unifund Corp.Court of Appeals for the Third Circuit · 2008
  2. Wolfington v. Reconstructive Orthopaedic Assocs. II PCCourt of Appeals for the Third Circuit · 2019
  3. John Zimmerman v. Thomas Corbett, Jr.Court of Appeals for the Third Circuit · 2017
  4. Glaxo, Inc., and Glaxo Group Limited v. Novopharm, Ltd.Court of Appeals for the Federal Circuit · 1997
  5. Warner-Lambert Company v. Apotex Corp., Apotex, Inc., and Torpharm, Inc.Court of Appeals for the Federal Circuit · 2003

7 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API